Synapse - Jason Konner

Results (156)

Assessing the genomic landscape of cervical cancers: Clinical opportunities and therapeutic targets

Journal Article

Friedman, C. F.; Ravichandran, V.; Miller, K.; Vanderbilt, C.; Zhou, Q.; Iasonos, A.; Vivek, M.; Mishra, P.; Leitao, M. M. Jr; Broach, V.; more...
Clinical Cancer Research (2023)

Fulltext@MSK | Save

Reply to Z.R. McCaw et al

Correspondence

Matulonis, U. A.; Lorusso, D.; Oaknin, A.; Pignata, S.; Dean, A.; Denys, H.; Colombo, N.; Van Gorp, T.; Konner, J. A.; Marin, M. R.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

A pilot study of lenvatinib plus pembrolizumab in patients with advanced sarcoma

Meeting Abstract

Movva, S.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Kelly, Ciara M.; Keohan, M. L.; Meyers, P. A.; Cohen, S. M.; Hensley, M. L.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Efficacy and safety of mirvetuximab soravtansine in patients with platinum-resistant ovarian cancer with high folate receptor alpha expression: Results from the SORAYA study

Journal Article

Matulonis, U. A.; Lorusso, D.; Oaknin, A.; Pignata, S.; Dean, A.; Denys, H.; Colombo, N.; Van Gorp, T.; Konner, J. A.; Marin, M. R.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Phase I study of a multivalent WT1 peptide vaccine (galinpepimut-S) in combination with nivolumab in patients with WT1-expressing ovarian cancer in second or third remission

Journal Article

Manning-Geist, B. L.; Gnjatic, S.; Aghajanian, C.; Konner, J.; Kim, S. H.; Sarasohn, D.; Soldan, K.; Tew, W. P.; Sarlis, N. J.; Zamarin, D.; more...
Cancers (2023)

Fulltext@MSK | Save

Long-term outcomes of patients with recurrent ovarian cancer treated with a polyvalent vaccine with bevacizumab combination

Journal Article

Kahn, R. M.; Ragupathi, G.; Zhou, Q. C.; Iasonos, A.; Kravetz, S.; Hensley, M. L.; Konner, J. A.; Makker, V.; Tew, W. P.; Aghajanian, C.; more...
Cancer Immunology, Immunotherapy (2023)

Fulltext@MSK | Save

Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study

Journal Article

Rubinstein, M. M.; Doria, E. R.; Konner, J.; Lichtman, S.; Zhou, Q.; Iasonos, A.; Sarasohn, D.; Troso-Sandoval, T.; Friedman, C.; O'Cearbhaill, R.; more...
Gynecologic Oncology (2023)

Fulltext@MSK | Save

Clinical benefit of mirvetuximab soravtansine in ovarian cancer patients with high folate receptor alpha expression: Results from the SORAYA Study

Meeting Abstract

Coleman, R. L.; Matulonis, U.; Lorusso, D.; Oaknin, A.; Pignata, S.; Denys, H.; Colombo, N.; Van Gorp, T.; Konner, J.; Marin, M. R.; more...
International Journal of Gynecological Cancer (2022)

Fulltext@MSK | Save

Efficacy and safety of mirvetuximab soravtansine in patients with platinum-resistant ovarian cancer with high folate receptor alpha expression: Results from the SORAYA study

Meeting Abstract

Matulonis, U.; Lorusso, D.; Oaknin, A.; Pignata, S.; Denys, H.; Colombo, N.; Van Gorp, T.; Konner, J.; Marin, M. R.; Harter, P.; more...
Gynecologic Oncology (2022)

Fulltext@MSK | Save

Exposure response (ER) analysis for efficacy and safety of mirvetuximab soravtansine (MIRV) in patients with folate receptor a (FR a)-positive cancer

Meeting Abstract

Matulonis, U. A.; Moore, K. N.; Lorusso, D.; Oaknin, A.; Pignata, S.; Denys, H.; Colombo, N.; Van Gorp, T.; Konner, J.; Romeo Marin, M.; more...
Annals of Oncology (2022)

Fulltext@MSK | Save